Management of refractory neuroblastoma with high-dose topotecan plus cyclophosphamide and vincristine.
- Author:
Jian CHANG
1
;
Yu-Tong ZHANG
;
Li-Zhe WANG
;
Xiao-Dan ZHONG
Author Information
1. Department of Pediatric Hematology and Oncology, First Hospital of Jilin University, Changchun, Jilin 130021, China.
- Publication Type:Journal Article
- MeSH:
Antineoplastic Combined Chemotherapy Protocols;
adverse effects;
therapeutic use;
Child, Preschool;
Cyclophosphamide;
administration & dosage;
Female;
Humans;
Male;
Neuroblastoma;
drug therapy;
Topotecan;
administration & dosage;
Vincristine;
administration & dosage
- From:
Chinese Journal of Contemporary Pediatrics
2014;16(2):120-123
- CountryChina
- Language:Chinese
